Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEAK: Panitumumab vs Bevacizumab in KRAS WT mCRC
NCT00819780Phase 2Completed
- Sponsor
- Amgen
- Start
- Apr 2009
- Primary completion
- May 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of panitumumab in metastatic colorectal cancer (mCRC), sponsored by Amgen. Started Apr 2009; status: completed.
02
Drugs
panitumumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00819780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00819780.